A couple of weeks ago we had the honour of hosting Dr John Bach for an exclusive webinar looking at how to manage the respiratory system of SMA sufferers.
Roche have released new data which shows that Risdiplam significantly improves motor function after 24 months in people between the ages of 2 and 25 years, this includes both type 2 and type 3 patients. In addition the data also shows that after 12 months of patients previously treated he continues to show a rapid and sustained increase in SMN protein levels.
We have received further clarity statement from the NHS England Clinical Panel for nusinersen with regards to access compassionate program for Risdiplam.
NICE and NHS have provided FAQs on adults accessing Spinraza.
It is with great sadness we announce the departure of Kacper from the TreatSMA team.
“When treatment was discussed in January and after the assessment was carried out I felt pleased but with the current situation (COVID-19) I thought it would never happen until I received the phone call telling me that it was going ahead and they had spaces at the RVI to do the treatment.”
Join us in a celebration of Carers Week 2020!
Results are in! Thank you to everyone who entered TreatSMA’s Great Lockdown Bake-off 2020. Everyone’s entries were truly amazing – guest judge Tom Herbert had a tough job on his hands picking a winner.